Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
79.88
+1.24 (1.58%)
Sep 18, 2025, 11:40 AM EDT - Market open
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $5.76 billion as of September 18, 2025. Its market cap has increased by 4.41% in one year.
Market Cap
5.76B
Enterprise Value
4.79B
1-Year Change
4.41%
Ranking
Category
Stock Price
$79.88
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $5.76B, an increase of 623.62%. That is a compound annual growth rate of 61.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 5.67B | 1.95% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.92B |
| Johnson & Johnson | 426.08B |
| AbbVie | 389.83B |
| UnitedHealth Group | 308.12B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 233.13B |